samedan logo
 
 
 
spacer
home > pmps > summer 2020 > synergistic relations
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Synergistic Relations

In this fast-paced and complex technical and regulatory environment, pharmaceutical and biotechnology companies are looking for new ways to become more efficient while building processes that deliver new drugs to market in a timely, cost-effective manner.

Partnerships or collaborations can enable an assortment of value- added benefits that can also lead to competitive advantage in the market. The concept of collaboration is about changing the functional business model from one that is vertical in nature to one that is a broader, network concept.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Fran DeGrazio has over 35 years’ experience in the pharma packaging and delivery industry, with extensive expertise in injectable drug products, including vial container closure systems, and pre-fillable systems for combination products. Fran has held numerous technical roles at West Pharmaceutical Services, Inc, including R&D, Quality & Regulatory, Technical Customer Support, Analytical Laboratories, and Scientific Affairs. In her current role as Chief Scientific Officer, she is responsible to leverage scientific and regulatory understanding across the enterprise. Fran received the Philadelphia Business Journal 2018 Healthcare Innovators of the Greater Philadelphia Region Award and the Healthcare Business Woman’s Association Luminary Award for West in 2017.
spacer
Fran DeGrazio at West Pharmaceutical Services, Inc
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Purification specialist BIA Separations to become part of Sartorius

Combination of businesses will create a premium portfolio for advanced therapies BIA Separations will be Sartorius’ center of excellence for purification of cell and gene therapeutics
More info >>

White Papers

The Emerging Use of Social Media in Orphan Disease Drug Research

Worldwide Clinical Trials Ltd

The use of various social media platforms, such as Twitter, Instagram, Facebook, and LinkedIn, for dissemination of clinical trial information has created a cornucopia of possibilities enabling clinical trial performance. Characterized by a people-to-people immediacy, social media permits extraordinarily adaptive modification of study information in real-time, and it does so in a highly targeted fashion.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement